falsefalse

Evolving Treatment Landscape in Myelodysplastic Syndromes - Episode 11

IMerge: Imetelstat in Patients With Lower-Risk MDS

, , ,

The expert panel discusses abstracts surrounding the IMerge clinical trial on imetelstat in patients with lower-risk myelodysplastic syndromes.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    x